FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) TREATMENT OF HCV INFECTION IN AN ITALIAN REAL-LIFE URBAN SETTING

被引：0
|
作者：
Di Paolo, D. [1 ]
Rossi, P. [1 ]
Lenci, I. [1 ]
Milana, M. [1 ]
Masetti, C. [1 ]
Santopaolo, F. [1 ]
Lionetti, R. [2 ]
D'Offizi, G. [2 ]
Pellicelli, A. [3 ]
Fondacaro, L. [3 ]
Siciliano, M. [4 ]
Tortora, A. [4 ]
Chiesara, F. [5 ]
Moretti, A. [5 ]
Ceccherini-Silberstain, F. [6 ]
Cento, V. [6 ]
Perno, C. F. [6 ]
Angelico, M. [1 ]
机构：
[1] Univ Roma Tor Vergata, Hepatol Unit, Rome, Italy
[2] Ist Nazl Malattie Infett Spallanzani, Hepatol Unit, Rome, Italy
[3] Osped S Camillo Roma, Hepatol Unit, Rome, Italy
[4] Policlin Gemelli, Hepatol Unit, Rome, Italy
[5] Osped S Filippo Neri, Hepatol Unit, Rome, Italy
[6] Univ Roma Tor Vergata, Virol Unit, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01472-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-132
引用
收藏
页码：S755 / S755
页数：1
相关论文
共 50 条
  • [21] Effectiveness and persistence of mirabegron as a first-line treatment in patients with overactive bladder in real-life practice
    Shin, Jung Hyun
    Choo, Myung-Soo
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (03) : 151 - 157
  • [22] Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study
    Paksoy, Nail
    Khanmammadov, Nijat
    Dogan, Izzet
    Ferhatoglu, Ferhat
    Ahmed, Melin Aydan
    Karaman, Sule
    Aydiner, Adnan
    MEDICINE, 2023, 102 (05) : E32866
  • [23] First-line treatment of nonsquamous NSCLC using gemcitabine: a retrospective study of real-life practice
    Kohutek, Filip
    Stratena, Miroslava
    Rosik, Andrej
    Tamasova, Maria
    Bystricky, Branislav
    LUNG CANCER MANAGEMENT, 2016, 5 (03) : 123 - 130
  • [24] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
    Annie Fourrier-Réglat
    Denis Smith
    Magali Rouyer
    Jacques Bénichou
    Rosine Guimbaud
    Yves Bécouarn
    Olivier Bernard
    Pernelle Noize
    Nicholas Moore
    Alain Ravaud
    Targeted Oncology, 2014, 9 : 311 - 319
  • [25] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
    Fourrier-Reglat, Annie
    Smith, Denis
    Rouyer, Magali
    Benichou, Jacques
    Guimbaud, Rosine
    Becouarn, Yves
    Bernard, Olivier
    Noize, Pernelle
    Moore, Nicholas
    Ravaud, Alain
    TARGETED ONCOLOGY, 2014, 9 (04) : 311 - 319
  • [26] 'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant
    Fabrizi, Fabrizio
    Alonso, Cristina
    Palazzo, Ana
    Anders, Margarita
    Virginia Reggiardo, Maria
    Cheinquer, Hugo
    Videla Zuain, Maria Grazia
    Figueroa, Sebastian
    Mendizabal, Manuel
    Silva, Marcelo
    Ridruejo, Ezequiel
    ANNALS OF HEPATOLOGY, 2021, 25
  • [27] Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil
    Sette-, Hoel, Jr.
    Cheinquer, Hugo
    Wolff, Fernando H.
    de Araujo, Alexandre
    Coelho-Borges, Silvia
    Soares, Silvia R. P.
    Barros, Mauricio F. A.
    ANNALS OF HEPATOLOGY, 2017, 16 (05) : 727 - 733
  • [28] Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients
    Piekarska, Anna
    Berkan-Kawinska, Aleksandra
    Berak, Hanna
    Mazur, Wlodzimierz
    Sitko, Marek
    Parfieniuk-Kowerda, Anna
    Lorenc, Beata
    Dybowska, Dorota
    Janczewska, Ewa
    Janocha-Litwin, Justyna
    Dobracka, Beata
    Socha, Lukasz
    Tudrujek-Zdunek, Magdalena
    Flisiak, Robert
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (09) : 775 - 780
  • [29] Direct acting antiviral (DAA) for treatment of chronic hepatitis C virus (HCV) infection: Early real-world data from Malaysia
    Chung, Yun Chien
    Tan, Soek Siam
    Chan, W. K.
    Leow, H. R.
    Tee, H. P.
    Chin, K. T.
    Hoe, C. H.
    Lee, Y. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 445 - 445
  • [30] NEW DIRECT ACTING ANTIVIRALS FOR HEPATITIS C TREATMENT: FIRST RESULTS IN A REAL-LIFE SETTING IN FRANCE
    Pariente, A.
    Remy, A. -J.
    Arpurt, J. -P.
    Rosa-Hezode, I.
    Renou, C.
    Arotcarena, R.
    Macaigne, G.
    Lison, H.
    Bourhis, F.
    Causse, X.
    Pauwels, A.
    de Montigny-Lenhardt, S.
    Jouannaud, V.
    Labadie, H.
    Maringe, E.
    Salloum, J. -H.
    Gagea, E.
    Hagege, H.
    Lesgourgues, B.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S632 - S632
12345